Lekston Andrzej, Slonka Grzegorz, Gasior Mariusz, Pres Damian, Gierlotka Marek, Zebik Tadeusz, Wasilewski Jaroslaw, Glowacki Jan, Polonski Lech
Third Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland.
Coron Artery Dis. 2010 Jan;21(1):13-9. doi: 10.1097/MCA.0b013e328333f56c.
Cardiogenic shock (CS) still remains one of the most important factors affecting the mortality rate of patients with ST segment elevation myocardial infarction (STEMI). However, the data with follow-up longer than 1 year are limited. The aim of this study was to evaluate the early and long-term treatment results of patients with STEMI, complicated or not by CS, who underwent percutaneus coronary interventions.
A retrospective registry included data of all patients with STEMI admitted to our centre from January 1999 to December 2001.
One thousand three hundred and eighty-five patients with STEMI were hospitalized and 1237 of them were treated with immediate percutaneus coronary interventions. Among this subpopulation, 117 (9.5%) patients were with STEMI complicated with CS on admission (group I) and 1120 (90.5%) patients were with STEMI without complications from CS on admission (group II). The groups differed significantly with regard to baseline clinical characteristics, angiographic picture, and in-hospital course. A total of 38.5% of patients with myocardial infarction complicated by CS and 2.5% of patients without shock (P<0.001) died during hospitalization. At the 5-year follow-up, 58.1% of group I patients and 14.8% of group II patients (P<0.001) died. A significant difference in the 5-year mortality rate was also observed in patients who survived the in-hospital period (31.9 vs. 12.6%; P<0.001).
CS continues to be closely connected with a very high mortality rate both in the hospital and in the long-term, also among patients who survived the in-hospital period.
心源性休克(CS)仍是影响ST段抬高型心肌梗死(STEMI)患者死亡率的最重要因素之一。然而,随访时间超过1年的数据有限。本研究的目的是评估接受经皮冠状动脉介入治疗的STEMI患者(无论是否合并CS)的早期和长期治疗结果。
一项回顾性登记研究纳入了1999年1月至2001年12月期间入住本中心的所有STEMI患者的数据。
1385例STEMI患者住院治疗,其中1237例接受了即刻经皮冠状动脉介入治疗。在这一亚组中,117例(9.5%)患者入院时为STEMI合并CS(I组),1120例(90.5%)患者入院时为STEMI且无CS并发症(II组)。两组在基线临床特征、血管造影表现和住院过程方面存在显著差异。心肌梗死合并CS的患者中有38.5%在住院期间死亡,无休克患者中有2.5%死亡(P<0.001)。在5年随访时,I组患者中有58.1%死亡,II组患者中有14.8%死亡(P<0.001)。在住院期间存活的患者中,5年死亡率也存在显著差异(31.9%对12.6%;P<0.001)。
CS在医院内和长期都与非常高的死亡率密切相关,在住院期间存活的患者中也是如此。